TLDR Some treatments for inflammatory bowel disease can cause skin problems like rashes and melanoma.
The document "Cutaneous side effects caused by treatment for inflammatory bowel disease" from 2016 discussed the skin-related side effects caused by treatments for inflammatory bowel disease. The study found that certain therapeutics, including immunosuppressive agents and biological therapy, could lead to drug hypersensitivity in the skin. Specific side effects included conditions like erythema nodosum and melanoma. The document did not provide the number of participants in the study.
60 citations
,
September 2013 in “Alimentary Pharmacology & Therapeutics” Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.
January 2022 in “Dermatology Review” Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.
15 citations
,
March 2021 in “Journal of clinical medicine” Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.
2 citations
,
September 2010 in “Journal of the Dermatology Nurses’ Association” Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.
1 citations
,
March 2024 in “BioDrugs” Biologics for severe asthma have known side effects, but some new risks need more study.
